Market Overview

Jim Cramer Weighs In On Valeant, Corning And Synergy Pharmaceuticals

Related VRX
Benzinga's Bulls & Bears Of The Week: Amazon, Costco, Netflix, Tesla And More
Dear Activists: Buying Stock Can Effect More Change Than Selling It
Weekly CFO Buys Highlight (GuruFocus)
Related GLW
Jim Cramer Gives His Opinion On Corning, McDonald's And More
Mylan, Hess, And 3 Other Stocks To Have On Your Radar This Week

Jim Cramer spoke on CNBC's Mad Money about Valeant Pharmaceuticals Intl Inc (NYSE: VRX). He thinks the company should do an equity offering to reduce its huge debt. There is still a large short position in the stock and some investors decided to cover it, because the downside is now quantified. He doesn't see Valeant as a good long position.

Cramer thinks Corning Incorporated (NYSE: GLW) is having a good run and the stock is a buy.

Cramer can't recommend Synergy Pharmaceuticals Inc (NASDAQ: SGYP) for anything other than a speculation. It's still in an early stage and it didn't report a good quarter.

Posted-In: CNBC Mad Money Jim CramerMedia


Related Articles (GLW + SGYP)

View Comments and Join the Discussion!